These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 15832508)

  • 1. A novel nucleoside prodrug-activating enzyme: substrate specificity of biphenyl hydrolase-like protein.
    Kim I; Song X; Vig BS; Mittal S; Shin HC; Lorenzi PJ; Amidon GL
    Mol Pharm; 2004; 1(2):117-27. PubMed ID: 15832508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure and specificity of a human valacyclovir activating enzyme: a homology model of BPHL.
    Kim I; Crippen GM; Amidon GL
    Mol Pharm; 2004; 1(6):434-46. PubMed ID: 16028355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a human valacyclovirase: biphenyl hydrolase-like protein as valacyclovir hydrolase.
    Kim I; Chu XY; Kim S; Provoda CJ; Lee KD; Amidon GL
    J Biol Chem; 2003 Jul; 278(28):25348-56. PubMed ID: 12732646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular basis of prodrug activation by human valacyclovirase, an alpha-amino acid ester hydrolase.
    Lai L; Xu Z; Zhou J; Lee KD; Amidon GL
    J Biol Chem; 2008 Apr; 283(14):9318-27. PubMed ID: 18256025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enzymatic activation of double-targeted 5'-O-L-valyl-decitabine prodrug by biphenyl hydrolase-like protein and its molecular design basis.
    Tao W; Zhao D; Sun M; Li M; Zhang X; He Z; Sun Y; Sun J
    Drug Deliv Transl Res; 2017 Apr; 7(2):304-311. PubMed ID: 28070705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular uptake mechanism of amino acid ester prodrugs in Caco-2/hPEPT1 cells overexpressing a human peptide transporter.
    Han HK; Oh DM; Amidon GL
    Pharm Res; 1998 Sep; 15(9):1382-6. PubMed ID: 9755889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of biphenyl hydrolase-like (BPHL) gene disruption on the intestinal stability, permeability and absorption of valacyclovir in wildtype and Bphl knockout mice.
    Hu Y; Epling D; Shi J; Song F; Tsume Y; Zhu HJ; Amidon GL; Smith DE
    Biochem Pharmacol; 2018 Oct; 156():147-156. PubMed ID: 30121252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nucleoside ester prodrug substrate specificity of liver carboxylesterase.
    Landowski CP; Lorenzi PL; Song X; Amidon GL
    J Pharmacol Exp Ther; 2006 Feb; 316(2):572-80. PubMed ID: 16223870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specificity of a prodrug-activating enzyme hVACVase: the leaving group effect.
    Sun J; Dahan A; Walls ZF; Lai L; Lee KD; Amidon GL
    Mol Pharm; 2010 Dec; 7(6):2362-8. PubMed ID: 21028903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel dipeptide prodrugs of acyclovir for ocular herpes infections: Bioreversion, antiviral activity and transport across rabbit cornea.
    Anand B; Nashed Y; Mitra A
    Curr Eye Res; 2003; 26(3-4):151-63. PubMed ID: 12815543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5'-Amino acid esters of antiviral nucleosides, acyclovir, and AZT are absorbed by the intestinal PEPT1 peptide transporter.
    Han H; de Vrueh RL; Rhie JK; Covitz KM; Smith PL; Lee CP; Oh DM; Sadée W; Amidon GL
    Pharm Res; 1998 Aug; 15(8):1154-9. PubMed ID: 9706043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carrier-mediated intestinal absorption of valacyclovir, the L-valyl ester prodrug of acyclovir: 1. Interactions with peptides, organic anions and organic cations in rats.
    Sinko PJ; Balimane PV
    Biopharm Drug Dispos; 1998 May; 19(4):209-17. PubMed ID: 9604120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of interaction between valaciclovir, the L-valyl ester of acyclovir, and Maalox antacid.
    de Bony F; Bidault R; Peck R; Posner J
    J Antimicrob Chemother; 1996 Feb; 37(2):383-7. PubMed ID: 8707752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of analogs of L-valacyclovir and determination of their substrate activity for the oligopeptide transporter in Caco-2 cells.
    Friedrichsen GM; Chen W; Begtrup M; Lee CP; Smith PL; Borchardt RT
    Eur J Pharm Sci; 2002 Jul; 16(1-2):1-13. PubMed ID: 12113886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Valacyclovir: a review of its antiviral activity, pharmacokinetic properties, and clinical efficacy.
    Beutner KR
    Antiviral Res; 1995 Dec; 28(4):281-90. PubMed ID: 8669888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclopropanecarboxylic acid esters as potential prodrugs with enhanced hydrolytic stability.
    Bender DM; Peterson JA; McCarthy JR; Gunaydin H; Takano Y; Houk KN
    Org Lett; 2008 Feb; 10(3):509-11. PubMed ID: 18181639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Valacyclovir HCl (Valtrex): an acyclovir prodrug with improved pharmacokinetics and better efficacy for treatment of zoster.
    Smiley ML; Murray A; de Miranda P
    Adv Exp Med Biol; 1996; 394():33-9. PubMed ID: 8815698
    [No Abstract]   [Full Text] [Related]  

  • 18. Synthesis and evaluation of 2-amino-6-fluoro-9-(2-hydroxyethoxymethyl)purine esters as potential prodrugs of acyclovir.
    Kim DK; Lee N; Im GJ; Kim HT; Kim KH
    Bioorg Med Chem; 1998 Dec; 6(12):2525-30. PubMed ID: 9925308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recognition of L-amino acid ester compounds by rat peptide transporters PEPT1 and PEPT2.
    Sawada K; Terada T; Saito H; Hashimoto Y; Inui KI
    J Pharmacol Exp Ther; 1999 Nov; 291(2):705-9. PubMed ID: 10525090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. L-valine ester of cyclopropavir: a new antiviral prodrug.
    Wu Z; Drach JC; Prichard MN; Yanachkova M; Yanachkov I; Bowlin TL; Zemlicka J
    Antivir Chem Chemother; 2009 Sep; 20(1):37-46. PubMed ID: 19794230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.